Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL03
- Pharmacological subgroupL03A
- Chemical subgroupL03AA
- Chemical substanceL03AA02Filgrastim
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Spain
AEMPS · 36 registrations
- Accofil 12 Mu/0,2 ML Solucion Inyectable y Para Perfusion en Jeringa Precargada0,12 mg · solución inyectable y para perfusión en jeringa precargada · Accord Healthcare S.L.U.
- Accofil 30 MU/0,5 ml solucion inyectable y para perfusion en jeringa precargada0,3 mg · solución inyectable y para perfusión en jeringa precargada · Accord Healthcare S.L.U. · 2 entries
- Accofil 48 MU/0,5 ml solucion inyectable y para perfusion en jeringa precargada0,48 mg · solución inyectable y para perfusión en jeringa precargada · Accord Healthcare S.L.U.
Netherlands
CBG-MEB · 18 registrations
At a glance
- ATC code
- L03AA02
- Registers
- 11
- Historical lists
- 2
- Registrations
- 159
- With their own page
- 122
- Companies
- 53
All medicines with Filgrastim
Human medicines from every register that match Filgrastim by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
162 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Filgrastim | Brazil | Authorised | Aché Laboratórios Farmacêuticos S.A | ||
| Filgrastim Hexal | European Union | Authorised | Hexal AG | ||
| Filgrastim Hexal | Croatia | Authorised | |||
| Filgrastim Injection 75 μG/0.3ML | Taiwan | 注射劑 | Authorised | 台灣大昌華嘉股份有限公司 | |
| Filgrastim Injection 150 μG/0.6ML | Taiwan | 注射劑 | Authorised | 台灣大昌華嘉股份有限公司 | |
| FILGRASTIM INJECTION M300,300µg/0.7ML | Taiwan | 注射劑 | Authorised | 台灣大昌華嘉股份有限公司 | |
| Filgrastim Hexal 30 ME, Oplossing voor injectie of infusie in voorgevulde spuit | Netherlands | Oplossing voor injectie of infusie | Authorised | Hexal AG | |
| Filgrastim Hexal 48 MU, Oplossing voor injectie of infusie in voorgevulde spuit | Netherlands | Oplossing voor injectie of infusie | Authorised | Hexal Biotech Forschungs GmbH | |
| Filkri | United States | 300MCG/0.5ML, 480MCG/0.8ML | injectable | Marketed | Accord Biopharma INC. |
| Neupogen | United States | 300MCG/1ML, 480MCG/1.6ML | vial | Marketed | Amgen |
| Neupogen | United States | 300MGC/0.5ML, 480MCG/0.8ML | syringe | Marketed | Amgen |
| Nypozi | United States | 300MCG/0.5ML, 480MCG/0.8ML | injectable | Marketed | Tanvex Biopharma USA INC |
| Releuko | United States | 300MCG/0.5ML, 480MCG/0.8ML | solution | Marketed | Kashiv Biosciences LLC |
| Releuko | United States | 300MCG/ML/VIAL, 480MCG/1.6ML/VIAL | solution | Marketed | Kashiv Biosciences LLC |
| Filgrastine | Brazil | Authorised | Blau Farmacêutica S.A. | ||
| Nivestym | United States | 300MCG/0.5ML, 480MCG/0.8ML | injectable | Marketed | Hospira INC |
| Nivestym | United States | 300MCG/ML, 480MCG/1.6ML | vial | Marketed | Hospira INC |
| Zarxio | United States | 300 mcg/0.5 mL, 480 mcg/0.8 mL | injectable | Marketed | Sandoz INC |
| Tevagrastim | European Union | Authorised | Teva GmbH | ||
| Ratiograstim | European Union | Authorised | Ratiopharm GmbH | ||
| Zarxio | United States | 300MCG/ML | Injection | Not marketed | Sandoz Inc. |
| Zarxio | United States | 480MCG/1.6ML | Injection | Not marketed | Sandoz Inc. |
| Nivestim | European Union | Authorised | Pfizer Europe MA EEIG | ||
| Grastofil | Canada | 480 MCG / 0.8 ML | Solution | Marketed | Apotex INC |
| Grastofil | Canada | 300 MCG / 0.5 ML | Solution | Marketed | Apotex INC |